Prophylaxis of Invasive Fungal Infections in Immunocompromised Patients
📧 Sign up to get email alerts when something new happens for Prophylaxis of Invasive Fungal Infections in Immunocompromised Patients.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-07-03FDA Approved: POSACONAZOLE — Supplemental Application (GLENMARK PHARMACEUTICALS INC., USA)
FDA approved a supplemental application for posaconazole submitted by Glenmark Pharmaceuticals Inc., USA, under an ANDA.